Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-01-21
1998-06-02
Grumbling, Matthew V.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544293, A61K 31505, C07D23994
Patent
active
057600414
ABSTRACT:
This invention provides a compound having the formula ##STR1## wherein: X is phenyl which is optionally substituted;
REFERENCES:
patent: 4343804 (1982-08-01), Munson et al.
patent: 5475001 (1995-12-01), Barker
patent: 5480883 (1996-01-01), Spada et al.
patent: 5580870 (1996-12-01), Barker et al.
patent: 5616582 (1997-04-01), Barker
Pellerano, C., et al., IL Farmaco 45(3):269-284 (1990).
Savini, L.., et al., IL Farmaco 48(6):805-825 (1993).
Dolle, R. E., et al., J. Med. Chem. 37:2627-2629 (1994).
Bridges, A. J., et al., J. Med. Chem. 39:267-276 (1996).
Fry, D.W. et al., Science, 265:1093-1095 (1994).
Ife, R. J. et al., J. Med. Chem. 35:3413-3422 (1992).
Maguire, M. P. et al., J. Med. Chem. 37:2129-2137 (1994).
Marecki, P. E. et al., Journal of Pharmaceutical Science 73:1141-1143 (1984).
Rewcastle, G. W. et al., J. Med. Chem. 38:3482-3487 (1995).
Sarges, R. et al., J. Med. Chem. 36:2828-2830 (1993).
Floyd, Jr. Middleton B.
Johnson Bernard D.
Kitchen Douglas B.
Wissner Allan
American Cyanamid Company
Grumbling Matthew V.
Milowsky Arnold S.
LandOfFree
4-aminoquinazoline EGFR Inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-aminoquinazoline EGFR Inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-aminoquinazoline EGFR Inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1460089